Watch Ticker

GRAIL, Inc. Common Stock

Go to GRAIL, Inc. Common Stock Website

$32.77

-0.02 (-0.06%)

Live

Previous Close

$32.79

Day Range

$32.66 - $33.4

Previous Day Range

$31.51 - $33.33

Market Cap

$1.2 billion USD

Day Vol.

115014

Previous Day Vol.

850629

Currency

USD

Primary Exchange

None

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem

The global Minimal Residual Disease (MRD) Testing Market is projected to reach $4.50 billion by 2030, with a 10.1% CAGR, driven by increasing cancer diagnostic needs and personalized medicine approaches.

Related tickers: EXAS, GRAL, GH, RHHBY.

Read Full Article

Vandana Singh - Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Quest Diagnostics reported strong Q1 2025 results, with revenue and earnings beating estimates. The company reaffirmed its full-year guidance and announced strategic acquisitions and partnerships, fueling confidence in its outlook.

Related tickers: DGX, FMS, GRAL.

Read Full Article

Trending Tickers

Please sign in to view